$NLNK Recent News Sarepta says its Ebola drug has no

New Post Public Reply Private Reply Replies (0) Message Board

Oct 20, 2014 at 11:18 AM

$NLNK Recent News

Sarepta says its Ebola drug has no ill effects 5:28 p.m. Oct. 16, 2014 - Russ Britt
Two biotechs staking claim in fight against Ebola 4:06 p.m. Oct. 16, 2014 - Russ Britt
Is there an Ebola bubble in these stocks? 3:22 p.m. Oct. 16, 2014 - Wallace Witkowski
AMD shares drop after hours 6:51 p.m. Oct. 13, 2014 - Wallace Witkowski
Fight against Ebola spreads to other nations 4:42 p.m. Oct. 13, 2014 - Russ Britt
Newlink shares jump on start of Ebola vaccine study 4:14 p.m. Oct. 13, 2014 - Wallace Witkowski
Ebola stocks: 2 to sell, and 5 to consider buying 12:09 p.m. Oct. 13, 2014 - The Trading Deck
Ebola vaccine use likely to be confined, experts say 7:28 a.m. Oct. 8, 2014 - Russ Britt
Number of companies fighting Ebola grows, one wins fed OK 4:09 p.m. Oct. 6, 2014 - Russ Britt
Meet the drug companies fighting Ebola 4:14 p.m. Oct. 3, 2014 - Russ Britt
Tesla climbs on product hint; Constellation falls 8:07 a.m. Oct. 2, 2014 - Ben Eisen
Getting Ebola treatments to market may take time 3:05 p.m. Oct. 1, 2014 - Russ Britt
Profiting from the fear as the market’s best quarter of the year begins 8:59 a.m. Oct. 1, 2014 - Shawn Langlois
Tekmira surges after Ebola report; ADP sinks 8:13 a.m. Oct. 1, 2014 - Ben Eisen
Use caution when investing in Ebola-related stocks 12:26 p.m. Aug. 28, 2014 - The Trading Deck
9 IPOs on tap; Angie's List, Delphi lead 2:11 p.m. Nov. 12, 2011 - MarketWatch.com

Why NewLink Genetics (NLNK) Stock Is Soaring Today 37 min ago - TheStreet.com
Heavy Trading On NewLink Genetics (NLNK) Before Market Open 9:16 a.m. Today - TheStreet.com
New Link Genetics and Genentech team up in cancer immunotherapy 7:51 a.m. Today - Seeking Alpha
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement For Development Of NLG919, An IDO Inhibitor In Phase 1, And Research Collaboration For The Discovery Of Next Generation IDO/TDO Inhibitors 6:01 a.m. Today - benzinga.com
Ebola Vaccine Push Ramps Up 7:54 p.m. Oct. 19, 2014 - The Wall Street Journal Interactive Edition
Canada Ships Out Experimental Ebola Vaccine 4:28 p.m. Oct. 18, 2014 - The Wall Street Journal Interactive Edition
Stomach-Churning Ride for Ebola Stocks 2:52 p.m. Oct. 17, 2014 - FOXBusiness
Healthcare Stocks in Focus on Ebola Fears - Analyst Blog 2:34 p.m. Oct. 17, 2014 - Zacks.com
Must See Charts: 4 Biotech Stocks to Watch in a Market Snapback 1:50 p.m. Oct. 17, 2014 - TheStreet.com
Obama appoints Ebola czar 1:35 p.m. Oct. 17, 2014 - Seeking Alpha
Making Money With Charles Payne: 10/16/14 6:00 p.m. Oct. 16, 2014 - FOXBusiness
Roller coaster ride continues for Ibio 9:09 a.m. Oct. 16, 2014 - Seeking Alpha
Second Texas Ebola case stokes the index 8:57 a.m. Oct. 15, 2014 - Seeking Alpha
Second healthcare worker contracts Ebola in U.S. 5:25 a.m. Oct. 15, 2014 - Seeking Alpha
Stock To Watch: NewLink Genetics (NLNK) In Perilous Reversal 10:11 a.m. Oct. 14, 2014 - TheStreet.com
NewLink Genetics (NLNK) Shows Strength: Stock Up 23.7% - Tale of the Tape 9:46 a.m. Oct. 14, 2014 - Zacks.com
Canada Launches Clinical Trials of Ebola Vaccine 1:54 p.m. Oct. 13, 2014 - The Wall Street Journal Interactive Edition
Ibio jumps on possible ZMapp production ramp 4:18 p.m. Oct. 10, 2014 - Seeking Alpha
Trade-Ideas: NewLink Genetics (NLNK) Is Today's Strong On High Relative Volume Stock 10:02 a.m. Oct. 10, 2014 - TheStreet.com
Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear 1:38 p.m. Oct. 9, 2014 - Investors Business Daily

NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors 8:22 a.m. Today - eTeligis
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors 7:01 a.m. Today - GlobeNewswire
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors 7:01 a.m. Today - Marketwired
Critical Alerts For NewLink Genetics, Orexigen Therapeutics, JinkoSolar, Randgold Resources and Arrowhead Research Released By InvestorsObserver 9:31 a.m. Oct. 16, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NewLink Genetics Corporation - NLNK 1:55 p.m. Oct. 2, 2014 - PR Newswire - PRF
Critical Alerts For AT&T, NewLink Genetics, Acuity Brands, Quintiles and Finish Line Released By InvestorsObserver 9:31 a.m. Oct. 2, 2014 - PR Newswire - PRF
NewLink Genetics Corporation Announces Appointment of New Executive Vice President and Chief Financial Officer 5:22 p.m. Oct. 1, 2014 - Marketwire
NewLink Genetics Corporation Announces Appointment of New Executive Vice President and Chief Financial Officer 5:14 p.m. Oct. 1, 2014 - eTeligis
FDA Gives NewLink Genetics Approval to Proceed to Phase 1 Clinical Studies of Their Ebola Vaccine 7:16 a.m. Sept. 4, 2014 - Marketwire
FDA Gives NewLink Genetics Approval to Proceed to Phase 1 Clinical Studies of Their Ebola Vaccine 7:01 a.m. Sept. 4, 2014 - eTeligis
Small companies lead the I-O class of Cancer Therapies 8:03 a.m. Aug. 8, 2014 - ACCESSWIRE
NewLink Genetics Corporation, Through Its Wholly Owned Subsidiary, BioProtection Systems Corporation, Secures a Letter Contract From the Defense Threat Reduction Agency for Testing and Evaluation of Ebola Virus Vaccine 7:16 a.m. Aug. 5, 2014 - Marketwire
NewLink Genetics Corporation Reports Second Quarter 2014 Financial Results 7:16 a.m. Aug. 5, 2014 - Marketwire
NewLink Genetics Corporation, Through Its Wholly Owned Subsidiary, BioProtection Systems Corporation, Secures a Letter Contract From the Defense Threat Reduction Agency for Testing and Evaluation of Ebola Virus Vaccine 7:01 a.m. Aug. 5, 2014 - eTeligis
NewLink Genetics Corporation Reports Second Quarter 2014 Financial Results 7:17 p.m. Aug. 4, 2014 - eTeligis
NewLink Genetics to Present at the XVIth International Congress of Virology 7:15 a.m. July 28, 2014 - Marketwire
NewLink Genetics to Present at the XVIth International Congress of Virology 7:00 a.m. July 28, 2014 - eTeligis
Biotech Equities Ahead of Market -- Research on Vertex Pharma, NewLink Genetics, ImmunoGen, and Synta Pharma 7:20 a.m. June 5, 2014 - PR Newswire - PRF
NewLink Genetics Demonstrates Continuing IDO Pathway Inhibitor Progress at ASCO 2014 Annual Meeting 2:35 a.m. June 5, 2014 - Marketwire
NewLink Genetics Dorgenmeltucel-L HyperAcute Immunotherapy for Melanoma Demonstrates Clinical Efficacy With Tumor Regression and Immune Activation 7:11 a.m. May 30, 2014 - Marketwire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Capricor Faces Lawsuit: Investors Should Take Note

Capricor Therapeutics: A Rough Road Ahead If you've got skin in the game with Capricor Therapeutics, these latest developments might have you feeling a bit queasy. Forget the greasy diner fare today; this situation calls for some serious contemplation and maybe a bit of antacid. Over at NASDAQ:CAPR, the air is hot with allegations, stock price nosedives, and looming legal...

CAPR Faces Lawsuit and FDA Delay: Investor Alert

Trouble Brewin' for Capricor Investors Buckle up, folks. Capricor Therapeutics (NASDAQ: CAPR) is caught in a storm, facing not just the lengthy arm of law with a securities class action, but also a seemingly endless wait with the FDA's decision on their lead product. We're talking serious implications for anyone with skin in the game. The FDA's Delayed Blessing So the...

Travel Smart: Support Wildlife, Avoid Exploitation

Rethink Wildlife Tourism for Ethical Travel You ever stopped to think about what those so-called wildlife attractions are really selling? It’s a feel-good illusion wrapped up in exploitation. Travelers often see animals as part of the backdrop of their holiday stories, but the reality is far from picturesque. Behind the photo ops, there's typically a grim story of...

ECRI Welcomes Safety Expert Meshkati to Its Board

The Safety Maverick Steps into Healthcare They've gone and done it—appointed a rockstar of systems safety to ECRI's Board of Trustees. Professor Najmedin Meshkati, who's practically been around every major industrial accident of the past few decades, is about to shake things up. Imagine the guy who's dissected calamities like the BP Texas City Refinery explosion and the...

United Imaging's CE Mark Ignites CT Innovation in Europe

United Imaging's Big Leap in CT Technology Listen up, folks. United Imaging just got the go-ahead to shake things up in Europe with their dual wide-coverage CT family. We're talking about the uCT SiriuX and the even more amped-up uCT SiriuX Ultrix. They’ve snagged the CE mark, a passport to roll out these impressive machines across the continent. Revolutionizing...

Cypress Wood's Resilience in Louisiana's Humidity

Timber Talk with Wes McAdams Diving into the nitty-gritty of building materials isn't everyone's cup of tea, but when you live in a place like Baton Rouge, understanding what stands up to the swampy summer heat is plain survival. The main focus? Cypress wood. Now, Wes McAdams from Cajun Cypress throws his hat into the ring, shedding some light on why cypress might just be...

Drones Propel Precision Agriculture Market's Skyrocketing Growth

Transforming Fields with a Bird's Eye View The old-school way of agricultural surveying is about as appealing as a broken plow in a rainstorm. Trudging across miles of farmland, hoping to spot issues before they turn into wallet-drainers—who's got time for that? Enter drones, the buzzing saviors of the modern farm. These high-tech marvels, loaded with multispectral and...

Innventure Faces Securities Lawsuit After 74% Stock Drop

Innventure's Stunning Plummet: A Lesson in Investor Caution Investors in Innventure, Inc. (NASDAQ: INV) got a harsh reminder of the market's volatility when the company's stock value nosedived by a staggering 74%. From May 27, 2026, just before the forensic bombshell by Morpheus Research, to August 14, 2026, Innventure's stock went from shaky to downright catastrophic....

Aurra Markets Wins 'Most Transparent Broker' Award 2026

Spotlight on Transparency in Trading Alright, so Aurra Markets snagged the 'Most Transparent Broker' award at the Money Expo in Mumbai this year. From the greasy streets of trading floors to the polished halls of Jio World Convention Centre, transparency is one of those golden words you hear tossed around, but like finding a needle in a haystack, it’s not always easy to...

Eluvio's Broadcast Revolution: Zero-Copy AI Streaming

The Game-Changing Shift in Broadcast Tech Eluvio's latest reveal at IBC 2026 shows they've taken the gloves off in the broadcast arena. They're pitching an all-in-one Global Broadcast Fabric that's turning heads with its zero-copy distribution and inline AI capabilities. No more dilly-dallying with satellites or cumbersome cloud solutions. Instead, they've cut right to...